PA
PJP icon

Procyon Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Procyon Advisors’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-900
Closed -$58K – 810
2020
Q2 		$58K Buy
+900
New +$55.9K 0.03% 360

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
AWMS
Advocacy Wealth Management Services Atlanta, Georgia $2.75B AUM 19.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Procyon Advisors's PJP Position: Q3 2020 in Review

Procyon Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2020, closing a stake of 900 shares — an estimated $58K sold.

Procyon Advisors first reported a position in PJP in Q2 2020 and held it in 1 quarter. The position peaked at $58K in Q2 2020. 83 funds tracked by Wall St. Rank hold PJP as of Q3 2020.

  • Procyon Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2020 after selling out during the quarter.
  • Procyon Advisors sold 900 Invesco Pharmaceuticals ETF shares in Q3 2020, an estimated $58K.
  • Procyon Advisors first reported a position in Invesco Pharmaceuticals ETF in Q2 2020 and held it in 1 quarter.
  • Procyon Advisors's Invesco Pharmaceuticals ETF position peaked at $58K in Q2 2020.
  • 83 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.